Filing Details

Accession Number:
0001209191-17-038425
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-06-07 19:03:20
Reporting Period:
2017-06-05
Filing Date:
2017-06-07
Accepted Time:
2017-06-07 19:03:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1396814 Pacira Pharmaceuticals Inc. PCRX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1296965 Marie Kristen Williams C/O Pacira Pharmaceuticals, Inc.
5 Sylvan Way, Suite 300
Parsippany NJ 07054
Cao And General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-06-05 1,877 $43.32 13,773 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.